J. Conard

发表

Acute Ischemic Stroke and Heparin Treatments

M. Bousser, M. Samama, P. Desnoyers, 1997, Thrombosis and Haemostasis.

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation

G. Raskob, A. Nicolaides, M. Griffin, 2008, International Angiology.

phospholipid binding and severe functional protein S deficiency Protein S Gla-domain mutations causing impaired Ca2+-induced

S. Rezende, D. Lane, J. Conard, 2013 .

Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiency.

S. Rezende, D. Lane, J. Conard, 2002, Blood.

Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency

M. Samama, J. Conard, G. Gerotziafas, 2012 .

Heparin-Induced Thrombocytopenia

G. Raskob, A. Nicolaides, M. Griffin, 2013, Thrombosis and Haemostasis.

Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases

M. Fontenay, I. Gouin-Thibault, O. Kosmider, 2020, Thrombosis and Haemostasis.

Treatment for Patients With Cancer

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Diagnosis and Anticoagulant Treatment *

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Key Questions to be Answered

G. Raskob, A. Nicolaides, M. Griffin, 2013 .

[Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)].

M. Bousser, J. Conard, C. Lecrubier, 1980, Annales de medecine interne.

Migraine and Haemostasis

M. Bousser, I. Crassard, J. Conard, 2001, Cephalalgia : an international journal of headache.

Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia

F. Rosendaal, G. Palareti, M. Makris, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Inferior Vena Cava Filters

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation.

M. Samama, I. Gouin-Thibault, I. Elalamy, 2002, Thrombosis research.

Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.

R. Bertina, K. Bauer, R. Rosenberg, 1988, Blood.

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency.

J. Griffin, A. Gruber, K. Bauer, 1993, Blood.

Oral Contraceptives, Hormone Replacement Therapy and Haemostasis

J. Conard, M. Samama, 2000, Cephalalgia : an international journal of headache.

Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency

P. Reitsma, F. Rosendaal, K. Bauer, 1996, Thrombosis and Haemostasis.

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.

C. Kluft, C. Kluft, M. Hellgren, 2009, Maturitas.

Hormone therapy and recurrence of venous thromboembolism among postmenopausal women

M. Horellou, J. Conard, P. Scarabin, 2011, Menopause.

TheWomen : Impact of the Route of Estrogen Administration and Progestogens : Hormone Therapy and Venous Thromboembolism Among Postmenopausal

E. Oger, J. Emmerich, H. Lévesque, 2007 .

M. Samama, J. Conard, P. Scarabin, 1988, Clinical science.

Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.

A. Vambergue, P. Gourdy, B. Vergès, 2012, Annales d'endocrinologie.

Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism

E. Oger, T. Simon, J. Emmerich, 2006, Journal of thrombosis and haemostasis : JTH.

[Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].

A. Gompel, M. Horellou, J. Conard, 2008, Gynecologie, obstetrique & fertilite.

Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies

A. Borel‐Derlon, J. Schved, J. Borg, 2001, BJOG : an international journal of obstetrics and gynaecology.

Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study

E. Oger, J. Emmerich, H. Lévesque, 2007, Circulation.

Clinical Aspects and Laboratory Problems in Hereditary Thrombophilia

M. Samama, M. Horellou, I. Elalamy, 1999, Pathophysiology of Haemostasis and Thrombosis.

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.

F. Chédru, M. Bousser, M. Samama, 1996, Stroke.

Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII.

H. Prydz, G. Mariani, F. Bernardi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Biochemistry and clinical pharmacology of new anticoagulant agents

M. Samama, M. Horellou, I. Elalamy, 2002, Pathophysiology of Haemostasis and Thrombosis.

Successful Progressive Anticoagulation in a Severe Protein C Deficiency and Previous Skin Necrosis at the Initiation of Oral Anticoagulant Treatment

J. Soria, J. Conard, M. Samama, 1984, Thrombosis and Haemostasis.

Pleiotropic effects of antithrombin strand 1C substitution mutations.

M. Hultin, M. Boisclair, D. Lane, 1992, The Journal of clinical investigation.

Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals

A. Deal, M. Moia, S. Middeldorp, 2016, European journal of haematology.

Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.

B. Guy-grand, P. Corvol, F. Elkik, 1986, Journal of Clinical Endocrinology and Metabolism.

CONGENITAL FACTOR VII DEFICIENCY AND CEREBROVASCULAR STROKE

M. Samama, J. Lefrère, M. Horellou, 1985, The Lancet.

L-ASPARAGINASE, ANTITHROMBIN III, AND THROMBOSIS

M. Horellou, J. Conard, M. Samama, 1980, The Lancet.

Impact of an Exercise-Induced Increase in Cardiac Troponin I in Chronic Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

G. Leone, E. Oger, B. Mercier, 2002 .

Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women

M. Samama, T. Lecompte, J. Conard, 1990, Thrombosis and Haemostasis.

Superficial Vein Thrombosis

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Recommendations on the Risk of Ischaemic Stroke Associated With Use of Combined Oral Contraceptives and Hormone Replacement Therapy in Women With Migraine

S. Silberstein, C. Tzourio, M. Bousser, 2000, Cephalalgia : an international journal of headache.

Fibrinogen and plasminogen modifications during oral estradiol replacement therapy.

A. Basdevant, A. Gompel, J. Conard, 1997, Fertility and sterility.

Biological Study of Intravenous Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial Infarction

J. Conard, J. Acar, M. Samama, 2012, Drugs.

The Problem and the Need for Prevention

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hereditary thrombophilia and fetal loss: a prospective follow‐up study

F. Rosendaal, G. Palareti, M. Makris, 2004, Journal of thrombosis and haemostasis : JTH.

Risk of thrombosis in patients homozygous for factor V Leiden.

M. Trossaërt, I. Elalamy, J. Conard, 1995, Blood.

Biological coagulation findings in third-generation oral contraceptives.

J. Conard, 1999, Human reproduction update.

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

R. Tait, S. Schulman, A. Mumford, 2008, Thrombosis and Haemostasis.

Progestogen-only contraception in women at high risk of venous thromboembolism.

J. Thalabard, M. Horellou, J. Conard, 2004, Contraception.

Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone

M. Samama, M. Horellou, I. Elalamy, 2003, British journal of haematology.

Heritable Thrombophilia and Pregnancy Associated Thrombosis.

M. Samama, M. Horellou, I. Elalamy, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Management of Pregnancy in Women with Thrombophilia

M. Samama, M. Horellou, J. Conard, 1999, Pathophysiology of Haemostasis and Thrombosis.

Problems of Oral Anticoagulation in an Adult with Homozygous Protein C Deficiency and Late Onset of Thrombosis

A. Ruskoné-Fourmestraux, J. Conard, P. Pescatore, 1993, Thrombosis and Haemostasis.

Gynecology and Obstetrics

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin

J. Conard, C. Lecrubier, M. Samama, 2005, Agents and Actions.

Prevention of Postthrombotic Syndrome

G. Raskob, A. Nicolaides, M. Griffin, 2013 .

Cerebral infarction and familial protein S deficiency.

P. Davous, J. Conard, M. Samama, 1990, Stroke.

Venous thrombosis and ovarian stimulation

A. Gompel, J. Conard, D. Lévy, 2006 .

Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery.

M. Samama, P. Girard, J. Conard, 1991, Thrombosis research. Supplement.

[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems].

F. Depasse, M. Samama, J. Conard, 2010, Annales pharmaceutiques francaises.

Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

A. Nicolaides, P. Prandoni, K. Myers, 2005, International angiology : a journal of the International Union of Angiology.

[Venous thromboembolic risk during repatriation for medical reasons].

E. Perrier, I. Lazareth, J. Conard, 2015, Journal des maladies vasculaires.

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

D. Archer, R. Sitruk-Ware, J. Conard, 2016, Contraception.

Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

B. Guy-grand, A. Basdevant, J. Conard, 1993, Contraception.

Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.

J. Ménard, J. Thalabard, R. Sitruk-Ware, 2007, The Journal of clinical endocrinology and metabolism.

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.

M. Horellou, I. Elalamy, J. Conard, 2005, Seminars in vascular medicine.

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency

J. Griffin, A. Gruber, K. Bauer, 1993 .

Congenital protein C deficiency and thrombotic disease in nine French families.

M. Samama, R. Bertina, J. Conard, 1984, British medical journal.

Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French study.

H. Massiou, A. Gompel, M. Horellou, 2014, Thrombosis research.

Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.

E. Kruithof, J. Conard, M. Samama, 1988, Blood.

Persistent Heparin Induced Thrombocytopenia Despite Therapy with Low Molecular Weight Heparin

A. Bernadou, M. Samama, G. D. Di Maria, 1984, Thrombosis and Haemostasis.

PREGNANCY AND CONGENITAL DEFICIENCY IN ANTITHROMBIN III OR PROTEIN C

M. Samama, J. Conard, M. Horellou, 1987, Thrombosis and Haemostasis.

Spontaneous platelet aggregation in heparin-treated patients.

M. Samama, J. Conard, C. Lecrubier, 1984, Acta haematologica.

Bnfices et risques des concentrs d'antithrombine III

J. Conard, 1992 .

First venous thromboembolism and hormonal contraceptives in young French women

A. Gompel, J. Hugon-Rodin, M. Horellou, 2017, Medicine.

Constitutional Thrombocytopathy with Subnormal Response to Thromboxane A2

B. Vargaftig, M. Lagarde, M. Chignard, 1981, British journal of haematology.

Problems on t-PA Specific Inhibitor Determination in Human Plasma

J. Conard, M. Samama, E. Szwarcer, 1985, Thrombosis and Haemostasis.

Laboratory Diagnosis of Antiphospholipid Antibodies

J. Conard, M. Samama, M. Horellou, 1997, Infectious diseases in obstetrics and gynecology.

Inhibitors and activation markers of the haemostatic system during hormone therapy: A comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone

J. Bonnar, C. Kluft, M. Hellgren, 2008, Thrombosis and Haemostasis.

Critical Care Medical Patients

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis.

Effects of long term administration of ticlopidine on platelet function and hemostatic variables.

M. Bousser, M. Samama, M. Horellou, 1980, Thrombosis research.

Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post‐thrombotic treatment

M. Samama, A. Chabanel, M. Horellou, 1994, British journal of haematology.

Frequency of the 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis.

V. Biousse, M. Bousser, J. Conard, 1998, Stroke.

Modified APC resistance assay for patients on oral anticoagulants

M. Trossaërt, H. Ireland, J. Conard, 1994, The Lancet.

Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol.

A. Basdevant, J. Conard, H. Degrelle, 1995, Fertility and sterility.

Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women.

A. Basdevant, J. Conard, H. Degrelle, 1991, Contraception.

COMPARISON OF THROMBOLYTIC, FIBRINOLYTIC, AND FIBRINOGENOLYTIC PROPERTIES OF TISSUE PLASMINOGEN ACTIVATOR, STREPTOKINASE, SINGLE‐CHAIN UROKINASE, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT UROKINASE IN HUMAN PLASMA IN VITRO

A. Vahanian, P. Desnoyers, J. Conard, 1988, Fundamental & clinical pharmacology.

Antithrombin III and atherosclerosis.

J. Conard, M. Samama, M. Castel, 1984, Advances in experimental medicine and biology.

Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients

M. Samama, J. Conard, J. Audouin, 1991, American journal of hematology.

Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.

J. Conard, M. Samama, A. Kher, 1981, Haemostasis.

Heparin-induced thrombocytopenia: laboratory diagnosis and management.

I. Elalamy, J. Conard, C. Lecrubier, 2000, Annals of medicine.

Multicentric Evaluation of a New Assay for Prothrombin Fragment F1+2 Determination

A. Tripodi, J. Conard, J. Reverter, 1992, Thrombosis and Haemostasis.

17 beta-Estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate.

J. Fiet, G. Cathelineau, J. Conard, 1995, Fertility and sterility.

Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.

J. Thalabard, G. Thomas, B. Guy-grand, 1986, The Journal of clinical endocrinology and metabolism.

Familial and constitutional bleeding disorder due to platelet cyclo‐oxygenase deficiency

B. Vargaftig, M. Chignard, F. Fouque, 1983, American journal of hematology.

α2-Antiplasmin Assay: Amidolytic and Immunological Method. Critical Evaluation. Results in a Clinical Material

J. Conard, N. Schlegel, M. Samama, 1980 .

Title Page / Table of Contents / Preface

F. Sofi, R. Abbate, P. Morange, 2003, Pathophysiology of Haemostasis and Thrombosis.

Molar antithrombin concentration in normal human plasma.

F. Brosstad, U. Abildgaard, J. Conard, 1983, Haemostasis.

Antithrombin III and hepatocellular carcinoma.

J. Lefrère, J. Conard, M. Samama, 1989, Thrombosis and haemostasis.

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies.

P. Mannucci, P. Mannucci, G. Finazzi, 1984, Blood.

Patients With Cancer

S. Kakkos, P. Prandoni, G. Raskob, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening

S. Thein, P. Mannucci, K. Bauer, 1993, British journal of haematology.

Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.

P. Kouides, F. Peyvandi, R. Kadir, 2005, Fertility and sterility.

Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy

Z. Amoura, N. Costedoat-Chalumeau, P. Lechat, 2008, Clinical pharmacology and therapeutics.

Genetic variants of factor VII.

J. Conard, M. Samama, K. Denson, 1972, Lancet.

Blood coagulation and platelet function: introduction.

B. Vargaftig, J. Conard, M. Samama, 1979, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

Prevention and Treatment of Venous Thromboembolism

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

At III content and antithrombin in activity in oestrogen-progestogen and progestogen-only treated women.

M. Samama, M. Horellou, J. Conard, 1980, Thrombosis research.

Antithrombin ‘DREUX’ (Lys114Glu): A Variant with Complete Loss of Heparin Affinity

Aiwu Zhou, R. Carrell, J. Huntington, 2002, Thrombosis and Haemostasis.

ANTITHROMBIN III AND THE ŒSTROGEN CONTENT OF COMBINED ŒSTRO-PROGESTAGEN CONTRACEPTIVES

J. Conard, M. Samama, Y. Salomon, 1972 .

ANTITHROMBIN III AND ORAL CONTRACEPTION WITH PROGESTAGEN-ONLY PREPARATION

J. Conard, M. Samama, J. Zorn, 1979, The Lancet.

Antithrombin 3 and the oestrogen content of combined oestro-progestagen contraceptives. (Letter to the editor)

J. Conard, M. Samama, Y. Salomon, 1972 .

Automated Amidolytic Method for AT III Determination

J. Conard, M. Samama, P. Barbier, 1979, Thrombosis and Haemostasis.

Differential AT III-Response to Oral and Parenteral Administration of 17 β-Estradiol

B. Guy-grand, A. Basdevant, J. Conard, 1983, Thrombosis and Haemostasis.

[Antithrombin 3 changes in women using oral contraceptives].

J. Conard, M. Samama, Y. Salomon, 1974, Pathologie et biologie.

Antithrombin activity and antigen

J. Conard, 1999 .

Antithrombin III activity and antigen

J. Conard, 1992 .

Screening for inherited thrombotic disorders

M. Horellou, J. Conard, M. Samama, 1989, La Ricerca in clinica e in laboratorio.

Treatment of Hereditary Protein C Deficiency with Stanozolol

C. Kluft, R. Bertina, J. Conard, 1987, Thrombosis and Haemostasis.

Multicenter Evaluation of a Chromogenic Substrate Method for Photometric Determination of Prothrombin Time

F. Dati, A. Girolami, M. Barthels, 1987, Thrombosis and Haemostasis.

[Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature].

P. Ffrench, J. Conard, M. Samama, 1995, Annales de medecine interne.

Heterogeneous mechanisms responsible for reduced fibrinolytic capacity in patients with a history of venous thrombosis

M. Samama, J. Conard, S. Combe, 1994 .

Laboratory control of SK therapy.

J. Conard, M. Samama, 1973, Thrombosis et diathesis haemorrhagica. Supplementum.

Comparative metabolic study of percutaneous versus oral micronized 17 beta-oestradiol in replacement therapy.

J. Conard, B Faguer de Moustier, J Conard, 1989, Maturitas.

Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor II.

M. Samama, J. Conard, L. Bara, 1986, Thrombosis research.

Automation of Antithrombin III Methods on Routinely Available Instruments

J. Conard, Ph. D. J. CONARD, 1983, Seminars in thrombosis and hemostasis.

A Multicenter Study on Amidolytic Factor X Evaluation in Oral Anticoagulant Therapy

A. Berthier, J. Conard, P. Scarabin, 1985, Thrombosis and Haemostasis.

Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration

E. Oger, J. Emmerich, H. Lévesque, 2005, Circulation.

Antithrombin III in Contraceptive Treatments with Oestroprogestagens or Progestagen -Only Pills

M. Samama, M. Horellou, J. Conard, 1979, Thrombosis and Haemostasis.

CONGENITAL DYSFIBRINOGENEMIA AND THROMBOSIS

J. Soria, J. Conard, M. Samama, 1988 .

Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis.

M. Samama, J. Conard, M. Horellou, 1988, Acta chirurgica Scandinavica. Supplementum.

Inhibitors of coagulation, atherosclerosis, and arterial thrombosis.

J. Conard, M. Samama, 1986, Seminars in thrombosis and hemostasis.

Multicenter Evaluation of Three Commercial Methods for Measuring Protein S Antigen

P. Mannucci, R. Bertina, N. Sala, 1992, Thrombosis and Haemostasis.

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

F R Rosendaal, F E Preston, F. Rosendaal, 2005, Journal of thrombosis and haemostasis : JTH.

DECREASE IN PROTEIN C IN L‐ASPARAGINASE‐TREATED PATIENTS

R. Zittoun, J. Conard, F. Potevin, 1985, British journal of haematology.

Antithrombin III In Patients Treated With Subcutaneous Or Intravenous Heparin

T. Lecompte, M. Horellou, J. Conard, 1981, Thrombosis and Haemostasis.

Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia

A. Kaider, F. Rosendaal, C. Legnani, 2012, Journal of thrombosis and haemostasis : JTH.

A new case of high‐molecular‐weight kininogen inherited deficiency

J. Lefrère, M. Horellou, J. Conard, 1986, American journal of hematology.

[Anticardiolipin antibodies and thrombosis].

J. Conard, M. Samama, M. Horellou, 1995, Presse medicale.

[Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study)].

A. Basdevant, J. Conard, M. Egloff, 1987, Contraception, fertilite, sexualite.

A single genetic origin for a common Caucasian risk factor for venous thrombosis.

J. Griffin, I. Pabinger, A. Eldor, 1997, Blood.

Orthopedic Surgery and Trauma

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

INCREASED SENSITIVITY OF PLATELETS TO ADRENALINE IN HUMAN MYOTONIC DYSTROPHY

M. Bousser, M. Samama, J. Conard, 1975, The Lancet.

Theoretic and Practical Considerations on Laboratory Monitoring of Thrombolytic Therapy

J. Conard, M. Samama, 1987, Seminars in thrombosis and hemostasis.

[Randiomized trial of a new platelet anti-aggregant agent: ticlopidine].

M. Bousser, M. Samama, J. Conard, 1977, Therapie.

Coagulation Assays as Diagnostic Markers of Hepatocellular Carcinoma

D. Dhumeaux, M. Beaugrand, J. Lefrère, 1988, Thrombosis and Haemostasis.

201 Bleeding complications of thrombolytic therpy in patients with acute myocardial infarction (M.I.) receiving I.V. infusion of SK or 1 chain rtPA

A. Vahanian, J. Conard, P. Michel, 1988 .

Severe prekallikrein deficiencies due to homozygous C529Y mutations.

P. de Mazancourt, M. Horellou, J. Conard, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

General, Vascular, Bariatric, and Plastic Surgical Patients

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis.

Familial thrombophilia and lifetime risk of venous thrombosis

F R Rosendaal, F E Preston, F. Rosendaal, 2004, Journal of thrombosis and haemostasis : JTH.

Diagnosis and clinical characteristics of inherited activated protein C resistance.

M. Trossaërt, I. Elalamy, J. Conard, 1996, Haemostasis.

[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].

M. Samama, M. Horellou, J. Conard, 2009, Journal des maladies vasculaires.

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago.

R. Bertina, P. Kyrle, J. Emmerich, 2006, Blood.

Prevention and treatment of venous thromboembolism--International Consensus Statement.

P Prandoni, G D Lowe, D Bergqvist, 2013, International angiology : a journal of the International Union of Angiology.

Atypical mutations of the prothrombin gene at positions 20 209 and 20 218, and a novel mutation at position 20 219. Report on 10 patients

J. Conard, L. Le Flem, C. Flaujac, 2007, Journal of thrombosis and haemostasis : JTH.

[Contribution of low doses in oral contraception].

J. Cohen, J. Conard, K. Fotherby, 1974, Contraception, fertilite, sexualite.

[The alcohol plasma gelation test in the diagnosis of disseminated intravascular coagulation].

J. Conard, M. Samama, J. Bousser, 1971, La Presse medicale.

Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest).

J. Conard, L. Bara, M. Samama, 1987, Haemostasis.

Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin necrosis

P. Reitsma, M. Samama, R. Bertina, 1992, The Lancet.

Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study

E. Oger, J. Emmerich, H. Lévesque, 2006, Journal of thrombosis and haemostasis : JTH.

Protein S Gla-domain mutations causing impaired Ca 2 (cid:1) -induced phospholipid binding and severe functional protein S deﬁciency

S. Rezende, D. Lane, J. Conard, 2002 .

Risk assessment models for thromboprophylaxis of medical patients.

M. Samama, M. Horellou, J. Conard, 2012, Thrombosis research.

Urologic Surgery

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cost-Effectiveness of Prevention and Treatment of VTE

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Fibrinogen Paris IX: a case of symptomatic hypofibrinogenemia with Bβ Y236C and Bβ IVS7‐1G→C mutations

P. de Mazancourt, J. Conard, V. Mathieux, 2006, Journal of thrombosis and haemostasis : JTH.

Single Point Mutation at Arg506 of Factor V Associated with APC Resistance and Venous Thromboembolism: Improved Detection by PCR-Mediated Site-Directed Mutagenesis

C. Boileau, J. Rabès, P. Giraudet, 1995, Thrombosis and Haemostasis.

The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis.

A. Girolami, W. Strauss, J. Conard, 1997, Hematology.

The Modified APC Resistance Test in the Presence of Factor V Deficient Plasma Can Be Used in Patients without Oral Anticoagulant

M. Trossaërt, M. Horellou, I. Elalamy, 1996, Thrombosis and Haemostasis.

Proposed classification of resistances to oral anticoagulant therapy.

J. Lefrère, J. Conard, M. Samama, 1987, Journal of clinical pathology.

Women's issues in thrombosis and hemostasis

V. Marder, B. Brenner, J. Conard, 2002 .

Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.

D. Lipsker, O. Dereure, T. Maisonobe, 2018, Acta dermato-venereologica.

Influence of Storage Conditions on Activated Protein C Resistance Assay

M. Trossaërt, J. Conard, M. Samama, 1995, Thrombosis and Haemostasis.

Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History

A. Gompel, J. Hugon-Rodin, M. Horellou, 2017, Journal of the Endocrine Society.

Inherited thrombophilia and gestational venous thromboembolism.

M. Samama, M. Horellou, J. Conard, 2003, Seminars in thrombosis and hemostasis.

[Coagulation and bronchopulmonary cancers: from clinical aspects to biology].

J. Conard, M. Samama, J. Bréchot, 1992, Revue des maladies respiratoires.

Low Levels of Protein S Activity in Factor V Depleted Plasma Used in APC Resistance Test

J. Amiral, I. Gouin-Thibault, J. Conard, 1998, Thrombosis and Haemostasis.

Vitamin K metabolism in a patient resistant to vitamin K antagonists.

M. Trossaërt, M. Samama, F. Parent, 1997, Haemostasis.

Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site

S. Thein, I. Pabinger, D. Lane, 1995 .

[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations].

M. Trossaërt, I. Elalamy, J. Conard, 1995, Presse medicale.

Increased fetal loss in women with heritable thrombophilia

F. Rosendaal, C. Legnani, M. Makris, 1996, The Lancet.

Thrombophilia

G. Raskob, S. Goldhaber, A. Turpie, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Combined Modalities in Surgical Patients

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Medical Patients

G. Geroulakos, A. Turpie, K. Myers, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Risk assessment models for thromboprophylaxis of medical patients.

M. Samama, M. Horellou, J. Conard, 2012, Thrombosis research.

[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].

K. Dellagi, J. Conard, M. Samama, 2006, Pathologie et biologie.

The fibrinolytic system in patients with congenital protein C deficiency.

M. Samama, R. Bertina, J. Conard, 1984, Thrombosis research.

Modifications of α2-Plasmin Inhibitor During Treatments by a Defibrinating Agent

J. Conard, M. Samama, B. Cazenave, 1979, Thrombosis and Haemostasis.

Prevention and Treatment of Venous Thromboembolism

G. Geroulakos, K. Myers, J. Conard, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Thrombolytic Therapy

G. Geroulakos, K. Myers, J. Conard, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention and treatment of venous thromboembolism

G. Raskob, A. Nicolaides, M. Griffin, 1990 .